GCIRX
Price
$13.99
Change
-$0.26 (-1.82%)
Updated
Apr 3 closing price
Net Assets
2.12B
VTPSX
Price
$131.42
Change
-$2.73 (-2.04%)
Updated
Apr 3 closing price
Net Assets
453.21B
Ad is loading...

GCIRX vs VTPSX

Header iconGCIRX vs VTPSX Comparison
Open Charts GCIRX vs VTPSXBanner chart's image
Goldman Sachs Intl Eq Insghts R
Price$13.99
Change-$0.26 (-1.82%)
VolumeN/A
Net Assets2.12B
Vanguard Total Intl Stock Idx InstlPls
Price$131.42
Change-$2.73 (-2.04%)
VolumeN/A
Net Assets453.21B
GCIRX vs VTPSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GCIRX vs. VTPSX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCIRX is a Buy and VTPSX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTPSX has more cash in the bank: 453B vs. GCIRX (2.12B). VTPSX pays higher dividends than GCIRX: VTPSX (3.15) vs GCIRX (1.79). GCIRX was incepted earlier than VTPSX: GCIRX (17 years) vs VTPSX (14 years). GCIRX (1.48) is less costly to investors than VTPSX (0.05). GCIRX is a more actively managed with annual turnover of: 167.00 vs. VTPSX (3.00). GCIRX has a lower initial minimum investment than VTPSX: GCIRX (0) vs VTPSX (100000000). VTPSX annual gain was more profitable for investors over the last year : 4.68 vs. GCIRX (4.14). GCIRX return over 5 years is better than : 79.96 vs. VTPSX (60.86).
GCIRXVTPSXGCIRX / VTPSX
Total Expense Ratio1.430.052,860%
Annual Report Gross Expense Ratio1.480.052,960%
Fund Existence17 years14 years-
Gain YTD9.2175.961155%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.12B453B0%
Annual Yield % from dividends1.793.1557%
Returns for 1 year4.144.6888%
Returns for 3 years18.895.71331%
Returns for 5 years79.9660.86131%
Returns for 10 years66.2731.26212%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHPIX23.70N/A
N/A
ProFunds Pharmaceuticals UltraSector Inv
NSNRX42.70N/A
N/A
Neuberger Berman Small Cap Growth R3
FCPVX19.24N/A
N/A
Fidelity Small Cap Value Fund
CFIAX13.89N/A
N/A
Columbia Flexible Capital Income A
MSAWX20.25N/A
N/A
Morgan Stanley Inst Asia Opp C